S&P 500 — US Large Cap Index
FTSE 100 — UK Blue Chips
Euro Stoxx 50 — Eurozone Leaders
DAX 40 — German Equities
CAC 40 — French Market Index
Nikkei 225 — Japan Benchmark
Hang Seng — Hong Kong Index
Shanghai Composite — China Mainland
ASX 200 — Australian Market
TSX Composite — Canada Index
Nifty 50 — India Large Cap
STI Index — Singapore Market
KOSPI — South Korea Index
Bovespa — Brazil Equities
JSE Top 40 — South Africa Index
IPC Index — Mexico Market
The FTSE 100 traded lower on Thursday, extending a 1.7% loss in the previous session, amid weakness in healthcare and energy stocks. AstraZeneca slumped 9% after its gene-silencing drug Wainua, developed with Ionis Pharmaceuticals, failed in a late-stage clinical trial to reduce heart complications in patients with a rare and potentially fatal cardiac disease. Energy majors also pressured the market, with Shell falling 0.8% and BP losing 1.3% as oil prices reversed earlier gains despite renewed tensions between the US and Iran. Concerns over the conflict, alongside uncertainty surrounding the durability of the ceasefire, have revived fears that higher energy prices could fuel inflation. Elsewhere, Severn Trent said trading remained in line with expectations after a strong start to its 2027 financial year. Meanwhile, the latest RICS survey showed UK house prices continued to decline in June, although the pace of falls eased slightly, suggesting the housing market may be stabilising.
Profit
Everyone's racing to cut costs. We're racing to create profit.
Start Selling through Service
